Developmental Biology & Stem CellsDNA Methylation and HydroxymethylationUncategorized

DNA Methylation in the Placenta: accelerated aging in pregnancy complications

DNA methylation in the placentaThe placenta is a unique organ as it is an extra-embryonic tissue primarily regulated by the fetal genome and shared between mother and fetus. However, it is a transient organ that is only needed throughout pregnancy and gestation and then is discarded after delivery. The essential role of the placenta in pregnancy is unquestionable but, surprisingly, as highlighted by the NIH NICHD Human Placenta Project (https://www.nichd.nih.gov/research/HPP/Pages/default.aspx), it is the human organ we know least about. Due to its unique features, the epigenetic mechanisms that regulate placental gene expression may not be under the same constraints as for other organs. We have recently reviewed the literature on DNA methylation in the placenta1 and highlighted the fact that this tissue is the most hypomethylated in the body when compared to other healthy tissues.2, 3 However, the reasons for this relative DNA hypomethylation are unknown. We do know that DNA methylation within the placenta increases across gestation.3-5 In addition, DNA methylation patterns in the placenta are characterized by large partially methylated domains in which the genes in these domains are repressed.6

Some of the unique characteristics of placental DNA methylation profiles are likely due to the different cell types that make up this organ and the distinct epigenetic profiles of these cell populations.1,7 A recent immunhiostochemical study8 has shown that there are differences in the amounts of 5-methylcytosine, 5-hydroxymethylcytosine, several histone modifications and the DNA methyltransferase enzymes between cytotrophoblasts and syncytiotrophoblasts. The latter are derived by the fusion of the former and conduct transport, biosynthetic and endocrine functions of the placenta that orchestrate both maternal adaptations to pregnancy, as well as nutrient delivery and waste services to the fetus.

A key focus of our research is identifying the dynamic changes in epigenetic state in the placenta across gestation to provide essential understanding of normal placental development and function at the molecular level. This is critical to elucidating what goes wrong in pregnancy complications. DNA methylation profiling, predominantly assessed through the use of arrays, has identified DNA methylation changes associated with pregnancy complications such as preeclampsia, intrauterine growth restriction, preterm birth and gestational diabetes. These pregnancy complications are associated with life-long health issues for both mother and baby. However, currently there is a paucity of research on this topic and little concordance between studies that have assessed DNA methylation in pregnancy complications. More research in this area in larger cohorts is required. Recently, we have taken a different approach by using publicly available DNA methylation data in placenta to perform a meta-analysis.9

In total, combining 12 different datasets we were able to analyse DNA methylation profiles of 387 placental tissues. We identified 741 CpG sites and 3 differentially methylated regions that significantly differed in placentas from uncomplicated versus preeclamptic pregnancies. A sex specific comparison between uncomplicated pregnancies (35 male and 27 female placentas) identified 2898 differentially methylated CpG sites, and not suprisingly the majority were on the X chromosome.

In 2013, Professor Steve Horvath developed the epigenetic clock (https://labs.genetics.ucla.edu/horvath/dnamage/). Horvath used Illumina DNA methylation arrays from 8000 samples across 51 healthy tissues and identified 353 CpG sites (epigenetic clock) that accurately predicted age across multiple healthy tissues.10 Since this work, the epigenetic clock has been applied in muliple datasets and human conditions and accelerated DNA methylation aging, the difference between predicted and actual age, has been associated with cancer, obesity, infection, neurodevelopmental diseases and many others. DNA methylation in blood predicts mortality irrespective of disease and lifestyle.11 We used a similar approach and identified 62 CpG sites that accurately predicted the gestational age of the placenta at sampling from 8-42 weeks’ gestation. When we assessed placentas from preeclamptic pregnancies, we found that accelerated placental aging was characteristic of early-onset preeclampsia (<34 weeks’ gestation) but not late-onset preeclampsia (>34 weeks’ gestation). This provides some insight into the molecular differences in the placenta from early-onset preeclampsia compared to those from uncomplicated pregnancy. Furthermore, our research questions the potential role of placental aging in other pregnancy complications in which the placenta is also implicated.

We are continuing to explore the role of epigenetic mechanisms and profile their change across gestation in placenta in normal and uncomplicated pregnancy with the aim of understanding the pathogenesis of these potentially life-threatening disorders.

Tina Bianco-Miotto1,2 and Claire T Roberts2,3
1Waite Research Institute, School of Agriculture, Food & Wine, University of Adelaide, SA, 5005, Australia
2Robinson Research Institute, University of Adelaide, SA, 5005, Australia
3Adelaide Medical School, University of Adelaide, SA, 5005, Australia

Original Article:

Mayne BT, Leemaqz SY, Smith AK, Breen J, Roberts CT, & Bianco-Miotto T (2016). Accelerated placental aging in early onset preeclampsia pregnancies identified by DNA methylation. Epigenomics PMID: 27894195

References:

1. Bianco-Miotto T, Mayne BT, Buckberry S, Breen J, Rodriguez Lopez CM, & Roberts CT (2016). Recent progress towards understanding the role of DNA methylation in human placental development. Reproduction (Cambridge, England), 152 (1) PMID: 27026712
2. Ehrlich M, Gama-Sosa MA, Huang LH, Midgett RM, Kuo KC, McCune RA, & Gehrke C (1982). Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic acids research, 10 (8), 2709-21 PMID: 7079182
3. Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, Miura K, Miyazaki T, Ogura C, Okazaki Y, & Jinno Y (2004). Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Annals of human genetics, 68 (Pt 3), 196-204 PMID: 15180700
4. Novakovic B, Yuen RK, Gordon L, Penaherrera MS, Sharkey A, Moffett A, Craig JM, Robinson WP, & Saffery R (2011). Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/stochastic factors. BMC genomics, 12 PMID: 22032438
5. Price EM, Cotton AM, Peñaherrera MS, McFadden DE, Kobor MS, & Robinson W (2012). Different measures of “genome-wide” DNA methylation exhibit unique properties in placental and somatic tissues. Epigenetics, 7 (6), 652-63 PMID: 22531475
6. Schroeder DI, Blair JD, Lott P, Yu HO, Hong D, Crary F, Ashwood P, Walker C, Korf I, Robinson WP, & LaSalle JM (2013). The human placenta methylome. Proceedings of the National Academy of Sciences of the United States of America, 110 (15), 6037-42 PMID: 23530188
7. Robinson WP, & Price EM (2015). The human placental methylome. Cold Spring Harbor perspectives in medicine, 5 (5) PMID: 25722473
8. Fogarty NM, Burton GJ, & Ferguson-Smith AC (2015). Different epigenetic states define syncytiotrophoblast and cytotrophoblast nuclei in the trophoblast of the human placenta. Placenta, 36 (8), 796-802 PMID: 26008948
9. Mayne BT, Leemaqz SY, Smith AK, Breen J, Roberts CT, & Bianco-Miotto T (2016). Accelerated placental aging in early onset preeclampsia pregnancies identified by DNA methylation. Epigenomics PMID: 27894195
10. Horvath, S. (2013). DNA methylation age of human tissues and cell types Genome Biology, 14 (10) DOI: 10.1186/gb-2013-14-10-r115
11. Marioni RE, Shah S, McRae AF, Chen BH, Colicino E, Harris SE, Gibson J, Henders AK, Redmond P, Cox SR, Pattie A, Corley J, Murphy L, Martin NG, Montgomery GW, Feinberg AP, Fallin MD, Multhaup ML, Jaffe AE, Joehanes R, Schwartz J, Just AC, Lunetta KL, Murabito JM, Starr JM, Horvath S, Baccarelli AA, Levy D, Visscher PM, Wray NR, & Deary IJ (2015). DNA methylation age of blood predicts all-cause mortality in later life. Genome biology, 16 PMID: 25633388

Previous post

Activated protein C ameliorates diabetic nephropathy (kidney disease) by epigenetically inhibiting the enzyme p66Shc

Next post

Non-coding RNA Expression is Synergistically modulated by Various Types of Epigenetic Modifications

Tina Bianco-Miotto

Tina Bianco-Miotto